Skip to main content
Livermore
Livermore
ZHEN

4D Molecular Therapeutics, Inc.

FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001650648

In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding 4D Molecular Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of FDMT: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders140146+6
Shares58.2M46.8M−11.4M (−19.6%)
Value$629.2M$260.6M−$368.5M (−58.6%)

New holders (33)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to FDMT in Q4 2024
InstitutionSharesValue% of portfolio
Peapod Lane Capital LLC144,743$806.2K0.80%
Raymond James Financial Inc112,904$628.9K0.00%
BNP Paribas Arbitrage, SA95,424$531.5K0.00%
HRT Financial LP83,419$464.0K0.00%
Verition Fund Management LLC77,813$433.4K0.00%
PDT Partners, LLC60,915$339.3K0.03%
Jain Global LLC53,586$298.5K0.01%
XTX Topco Ltd36,939$205.8K0.02%
Acadian Asset Management LLC33,289$185.0K0.00%
Corton Capital Inc.32,722$182.3K0.10%
Zuckerman Investment Group, LLC20,000$118.6K0.01%
Marquette Asset Management, LLC20,860$116.2K0.02%
Axq Capital, LP19,753$110.0K0.05%
Simplex Trading, LLC14,731$82.0K0.00%
Fox Run Management, L.L.C.12,309$68.6K0.01%
Police & Firemen's Retirement System of New Jersey10,018$55.8K0.00%
Velan Capital Investment Management LP10,000$55.7K0.05%
Point72 Asia (Singapore) Pte. Ltd.9,025$50.3K0.01%
KLP Kapitalforvaltning AS8,600$47.9K0.00%
Point72 (DIFC) Ltd6,866$38.2K0.00%
Federated Hermes, Inc.3,762$21.0K0.00%
Group One Trading, L.P.3,711$20.7K0.00%
Meeder Asset Management Inc1,394$7.76K0.00%
GF Fund Management Co. Ltd.971$5.41K0.00%
Creative Planning517$2.88K0.00%
Quadrant Capital Group LLC463$2.58K0.00%
Red Tortoise LLC288$1.60K0.00%
Aventura Private Wealth, LLC110$6130.00%
CoreCap Advisors, LLC82$4570.00%
Comerica Bank77$4290.00%
SBI Securities Co., Ltd.35$1950.00%
Caitong International Asset Management Co., Ltd31$1730.00%
IFP Advisors, Inc0$60.00%

Sold out (27)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of FDMT in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Polar Capital Holdings Plc838,492$9.06M
Eagle Health Investments LP462,911$5.00M
Eventide Asset Management, LLC422,856$4.57M
Kennedy Capital Management, Inc.351,653$3.80M
Panagora Asset Management Inc100,973$1.09M
Platinum Investment Management Ltd100,863$1.09M
Rafferty Asset Management, LLC90,348$976.7K
Walleye Capital LLC84,322$911.5K
Twinbeech Capital LP76,310$824.9K
Squarepoint Ops LLC50,320$544.0K
Sphera Funds Management Ltd.48,702$526.5K
Skandinaviska Enskilda Banken AB (publ)44,600$482.1K
Franklin Resources Inc34,781$314.1K
Aquatic Capital Management LLC27,500$297.3K
Y-Intercept (Hong Kong) Ltd24,538$265.3K
Graham Capital Management, L.P.19,773$213.7K
Ameriprise Financial Inc19,395$209.7K
Dark Forest Capital Management LP18,717$202.3K
Profund Advisors LLC18,142$196.1K
Point72 Asset Management, L.P.15,341$165.8K
ADAR1 Capital Management, LLC6,000$64.9K
Values First Advisors, Inc.5,315$57.5K
nVerses Capital, LLC3,700$40.0K
Russell Investments Group, Ltd.175$1.89K
Rothschild Investment LLC35$378
Allspring Global Investments Holdings, LLC27$291
Bessemer Group Inc20$0